Literature DB >> 31837325

Telomere-associated genes and telomeric lncRNAs are biomarker candidates in lung squamous cell carcinoma (LUSC).

Camila Baldin Storti1, Rogério Antônio de Oliveira2, Márcio de Carvalho3, Erica Nishida Hasimoto4, Daniele Cristina Cataneo4, Antonio José Maria Cataneo4, Júlio De Faveri5, Elton José R Vasconcelos6, Patrícia Pintor Dos Reis7, Maria Isabel Nogueira Cano8.   

Abstract

In the past decade, research efforts were made to identify molecular biomarkers useful as therapeutic targets in Non-Small Cell Lung Cancer (NSCLC), the most frequent type of lung carcinoma. NSCLC presents different histological subtypes being the most prevalent LUSC (Lung Squamous Cell Cancer) and LUAD (Lung Adenocarcinoma), and only a subset of LUAD patients' present tumors expressing known targetable genetic alterations. Telomeres and its components, including telomerase, the enzyme that replenishes telomeres, have been considered potential cancer biomarkers due to their crucial role in cell proliferation and genome stability. Our study aims to quantify expression changes affecting telomere-associated genes and ncRNAs associated with telomere regulation and maintenance in NSCLC. We first assessed the transcriptome (RNA-Seq) data of NSCLC patients from The Cancer Genome Atlas (TCGA) and then we tested the expression of telomere-associated genes and telomeric ncRNAs (TERC, telomerase RNA component, and TERRA, telomere repeat-containing RNA) in Brazilian NCSLC patient samples by quantitative RT-PCR, using matched normal adjacent tissue samples as the control. We also estimated the mean size of terminal restriction fragments (TRF) of some Brazilian NSCLC patients using telomeric Southern blot. The TCGA analysis identified alterations in the expression profile of TERT and telomere damage repair genes, mainly in the LUSC subtype. The study of Brazilian NSCLC samples by RT-qPCR showed that LUSC and LUAD express high amounts of TERT and that although the mean TRF size of tumor samples was shorter compared to normal cells, telomeres in NSCLC are probably maintained by telomerase. Also, the expression analysis of Brazilian NSCLC samples identified statistically significant alterations in the expression of genes involved with telomere damage repair, as well as in TERC and TERRA, mainly in the LUSC subtype. We, therefore, concluded that telomere maintenance genes are significantly deregulated in NSCLC, representing potential biomarkers in the LUSC subtype.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  LUAD; LUSC; Molecular biomarkers; Non-small cell lung cancer; Telomere-associated genes; Telomeres; Telomeric ncRNAs

Year:  2019        PMID: 31837325     DOI: 10.1016/j.yexmp.2019.104354

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  8 in total

1.  Identification of Prognostic and Tumor Microenvironment by Shelterin Complex-Related Signatures in Oral Squamous Cell Carcinoma.

Authors:  Suwei Zhang; Hanhui Yu; Jiazhen Li; Liang Zhao; Lei Tan; Qiang Song; Cong Sun
Journal:  Oxid Med Cell Longev       Date:  2022-06-15       Impact factor: 7.310

2.  Exosomal long noncoding RNA AGAP2-AS1 regulates trastuzumab resistance via inducing autophagy in breast cancer.

Authors:  Xueke Qian; Hongbo Qu; Fan Zhang; Shujia Peng; Dongwei Dou; Yunqing Yang; Yichao Ding; Mingwei Xie; Huaying Dong; Yue Liao; Mingli Han
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

3.  MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer.

Authors:  Jing Han; Hongbo Qu; Mingli Han; Yichao Ding; Mingwei Xie; Jianguo Hu; Yuanwen Chen; Huaying Dong
Journal:  Oncogene       Date:  2020-12-03       Impact factor: 9.867

Review 4.  Non-canonical roles of canonical telomere binding proteins in cancers.

Authors:  Semih Can Akincilar; Claire Hian Tzer Chan; Qin Feng Ng; Kerem Fidan; Vinay Tergaonkar
Journal:  Cell Mol Life Sci       Date:  2021-02-18       Impact factor: 9.261

5.  Insertion of Telomeric Repeats in the Human and Horse Genomes: An Evolutionary Perspective.

Authors:  Marco Santagostino; Francesca M Piras; Eleonora Cappelletti; Simone Del Giudice; Ornella Semino; Solomon G Nergadze; Elena Giulotto
Journal:  Int J Mol Sci       Date:  2020-04-18       Impact factor: 5.923

6.  LncRNA WT1-AS/miR-494-3p Regulates Cell Proliferation, Apoptosis, Migration and Invasion via PTEN/PI3K/AKT Signaling Pathway in Non-Small Cell Lung Cancer.

Authors:  Chaohui Wu; Jiansheng Yang; Rongbin Li; Xianbin Lin; Jiayun Wu; Jingyang Wu
Journal:  Onco Targets Ther       Date:  2021-02-09       Impact factor: 4.147

7.  Identification of a 5-lncRNA-Based Signature for Immune Characteristics and Prognosis of Lung Squamous Cell Carcinoma and Verification of the Function of lncRNA SPATA41.

Authors:  Sheng Huan; Miao Chen; Sumin Sun; Yanling Zhong; Yu Chen; Yihao Ji; Guoping Yin
Journal:  Front Genet       Date:  2022-08-29       Impact factor: 4.772

8.  Epigenetic Deregulation of Telomere-Related Genes in Newly Diagnosed Multiple Myeloma Patients.

Authors:  Samrat Roy Choudhury; Cody Ashby; Fenghuang Zhan; Frits van Rhee
Journal:  Cancers (Basel)       Date:  2021-12-17       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.